Table 3.
Spearman Rho correlations between plasma miRNA-4739 level and CLI risk factors in T2DM patients.
| Variable | miRNA-4739 | |
|---|---|---|
| T2D Duration | rho | 0.113 |
| p | 0.408 | |
| Hypertension | rho | 0.094 |
| p | 0.492 | |
| Smoking | rho | 0.175 |
| p | 0.197 | |
| ABI | rho | -0.284 |
| p | 0.034 | |
| FPG | rho | 0.391 |
| p | 0.003 | |
| HbA1c | rho | 0.297 |
| P | 0.026 | |
| TC | rho | -0.127 |
| p | 0.350 | |
| Cr | rho | -0.131 |
| p | 0.336 |
ABI, ankle brachial index; FPG, fasting plasma glucose; HbA1c, glycosylated hemoglobin; TC, total cholesterol; Cr, serum creatinine. All study subjects were included in the analysis. Significant values are marked in italic.